Article citationsMore>>

Diousse, P., Berthé, A., Done, H., Touré, P.S., Bammo, M., Seck, F., Guèye, N., Diop, M.M., Faye, F.A., Dieng, M.T., Diop, B.M. and Ka, M.M. (2017) Profil épidémio clinique des maladies auto-immunes systémiques dans le service de Dermatologie. Revue Africaine de Médecine Interne, 4, 18-21.

has been cited by the following article:

• TITLE: Difficulties in the Management of Systemic Autoimmune Diseases in Saint-Louis Du Senegal through the Analysis of a Series of 70 Observations

  AUTHORS: Diatou G. Dia, Amadou D. Dia, Nafissatou Diagne, Awa C. Ndao, Cheikh T. Tall, Blaise M. Ngouamba

  KEYWORDS: Systemic Autoimmune Diseases, Polyarthritis, Systemic Lupus Erythematosus, Saint-Louis Du Senegal

  JOURNAL NAME: Open Journal of Internal Medicine, Vol.11 No.4, December 24, 2021

  ABSTRACT: Introduction: Systemic Autoimmune Diseases (SAID) long considered very rare in Africa are increasingly the subject of publications. The objective of this work is to identify the difficulties in the management of these pathologies in an internal medicine department in northern Senegal by analyzing the epidemiological, clinical-biological, therapeutic and evolutionary aspects of SAID. Methods: This was a descriptive cross-sectional study carried out in the internal medicine department of the Saint-Louis University Hospital Center. Included were all the files of patients followed in outpatient and/or hospitalization for autoimmune diseases according to the criteria of the American College of Rheumatology, during the period from January 2017 to December 2020. The data were analyzed using SPSS software version 21.0. As the study was descriptive, no statistical test was performed. Results: Out of 3800 patients, 70 presented SAID, i.e. a hospital prevalence of 1.8%. Polyarthritis was the first reason for consultation in 97% followed by skin manifestations in 8%. The patients had positive anti-nuclear autoantibodies in 88% of cases. Rheumatoid arthritis was the predominant condition (71%) followed by systemic lupus erythematosus (SLE) (15%) and undifferentiated autoimmune diseases in 10%. Eleven percent (11%) of patients had an associated autoimmune disease. Corticosteroids were used in the treatment of these conditions in 97% of cases and methotrexate was the most prescribed immunosuppressant (54%). Thirty-two percent (32%) of patients are lost to follow-up. Conclusion: SAID are diverse and under diagnosed; they are characterized by diagnostic delay above all linked to access to specialists and sometimes to the high cost of paraclinical examinations, in particular immunology. Treatment remains based primarily on corticosteroid therapy and conventional immunosuppressants in the face of the unavailability of biotherapies.